second-line - Globe Thesis

Keyword [second-line] Result: 1 - 20 \| Page: 1 of 7
1.	Comparative Study Of EML4-ALK Gene Expression In NSCLC Treated With Second-line Chemotherapy And Targeted Therapy Of Wild Type NSCLC
2.	Effect Of Common EGFR Mutant Genotype On Second - Line Treatment Strategy Of Advanced Lung Adenocarcinoma
3.	Significance Of Serum VEGF In Lung Cancer And Angiogenic Inhibitors In The Treatment Of Advanced Non-Small Cell Lung Cancer
4.	The Clinical Prognostic Factors And Treatment In Advanced Non-small Cell Lung Cancer
5.	Plasma Rna And Pbmcs Dna Hiv-1 Drug-resistant Quasispecies Polymorphism And Molecular Evolutionary Studies
6.	Clinical Study Of Shenqi Fuzheng Injection With Pemetrexed On Second-Line Treatment Of Advanced Stage Non-Small Cell Lung Cancer
7.	Clinical Observation Of Pemetrexed Monotherapy Or Combination Regimen As Second-line Treatment For Advanced Non-small Cell Lung Cancer
8.	Systematic Review On Curative Effects Of Pemetrexed And Docetaxel As A Second-line Regimen In The Therapy Of Advanced Non-small Cell Lung Cancer In Elderly Patients
9.	Clinical Observation In Second-Line Treatment Of Advanced Non-Small Cell Lung Cancer Of Pemetrexed Compared With Gefitinib
10.	The Analysis Of Prognostic Determinants And The Therapeutic Effect Of Second-line Regimen Of 298 Cases Of Advanced NSCLC
11.	The Chemotherapy Efficacy And Prognosis Analysis Of Advanced Non Small Cell Lung Cancer
12.	Molecular Detection Of Mutations Associated With First And Second-Line Drug Resistance In Extensively Drug Resistance Tuberculosis And The Mechanism Inducing Drug Resistance In China
13.	Resistance To Second-line Drugs In First-line Drugs Resistance TB Patients In Shanghai And The Relationship Between Resistant To Second-line Drugs And Gene Loci In Beijing Family Mycotacterium Tuberculosis
14.	The Relationship Between Epithelial-mesenchymal Transition, The Expression Of IGF-1R And Efficacy Of Gefitinib As The Second Line Treatment For Advanced Non-small Cell Lung Cancer
15.	A Study On The Usage Of Second-line Anti-tuberculosis Drugs And Drug Susceptibility Testing For Anti-tuberculosis Drugs In China
16.	Effectiveness Of Erlotinib As The Sennd-line Therapy In Patients With Advanced NSCLC
17.	Efficacy And Cost-effectiveness Analysis Of The Second-line Treatment For Advanced Non-small-cell Lung Cancer
18.	Study On Recurrent Tuberculosis And Resistance To Second-line Drugs In Mycobacterium Tuberculosis
19.	Effect Analysis Of Pemetrexed Disodium Single As Second-line Chemotherapy In Advanced Non-squamous Non-small Cell Lung Cancer
20.	Clinical Study Of ATP Tumor Chemosensitivity Assay In The Second-line Chemotherapy Of Lung Adenocarcinoma
<<First <Prev Next> Last>> Jump to